Results 21 to 30 of about 33,657 (222)
BioDrugs, 2022 Dengue is one of the most prevalent mosquito-borne diseases in the world, affecting an estimated 390 million people each year, according to models. For the last two decades, efforts to develop safe and effective vaccines to prevent dengue virus (DENV) infections have faced several challenges, mostly related to the complexity of conducting long-term ...
Jesús M. Torres-Flores +2 more
openaire +2 more sources
BMC Infectious Diseases, 2020 Background Dengue fever is a major public health problem in Colombia. A fever surveillance study was conducted for evaluation of the clinical, epidemiological, and molecular patterns of dengue, prior to Chikungunya and Zika epidemics. Methods In November
Jacqueline Kyungah Lim +8 more
doaj +1 more source
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. [PDF]
PLoS Pathogens, 2013 With 2.5 billion people at risk, dengue is a major emerging disease threat and an escalating public health problem worldwide. Dengue virus causes disease ranging from a self-limiting febrile illness (dengue fever) to the potentially fatal dengue ...
Raphaël M Zellweger +5 more
doaj +1 more source
Lipidated dengue-2 envelope protein domain III independently stimulates long-lasting neutralizing antibodies and reduces the risk of antibody-dependent enhancement. [PDF]
PLoS Neglected Tropical Diseases, 2013 BACKGROUND: Dengue virus is a mosquito-transmitted virus that can cause self-limiting dengue fever, severe life-threatening dengue hemorrhagic fever and dengue shock syndrome.
Chen-Yi Chiang +9 more
doaj +1 more source
Archives of the Balkan Medical Union, 2022 Dengue is estimated to be the most common mosquito-borne disease globally, affecting mainly tropical and subtropical countries. It has been identified as a disease of the future, due to persistent trends in urbanization of societies, scarce water resources and changes in the environment. The four dengue virus serotypes cause from the usual mild illness
Radka KOMITOV +3 more
openaire +2 more sources
BMC Public Health, 2022 Background Dengue vaccine is a promising alternative for protecting communities from dengue. Nevertheless, public acceptance of the dengue vaccine must be considered before the authorities decide to carry out intensified research and recommend the ...
Ahmad Firdhaus Arham +6 more
doaj +1 more source
Vaccines, 2022 Infection with viruses belonging to the genus Flavivirus, such as Japanese encephalitis virus (JEV) and dengue virus (DENV), is a worldwide health problem. Vaccines against JEV and DENV are currently available.
Tomohiro Kotaki +4 more
doaj +1 more source
Pathogenesis of Dengue: Dawn of a New Era [version 1; referees: 3 approved]
F1000Research, 2015 Dengue virus (DENV) infections of humans were long thought to be self-limited and of low mortality. Beginning in the 1950s, at the time when four different DENVs were discovered, a lethal variant of dengue emerged.
Scott B. Halstead
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 In 2019, Bangladesh has grappled with a record-breaking surge in dengue fever, experiencing the highest number of dengue cases since the year 2000. Together, the intensification of dengue fever combined with a lack of dengue vaccines and appropriate ...
K M Ariful Kabir +2 more
doaj +1 more source